Phio Pharmaceuticals Files 2024 10-K
Ticker: PHIO · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1533040
| Field | Detail |
|---|---|
| Company | Phio Pharmaceuticals Corp. (PHIO) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Phio Pharma's 2024 10-K is in. Check financials for the year ending Dec 31, 2024.
AI Summary
Phio Pharmaceuticals Corp. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly RXi Pharmaceuticals Corp., is focused on pharmaceutical preparations. Its principal executive offices are located in Marlborough, Massachusetts.
Why It Matters
This filing provides a comprehensive overview of Phio Pharmaceuticals' financial health and operational status for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Phio Pharmaceuticals is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-31 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Phio Pharmaceuticals Corp. (company) — Filer of the 10-K
- RXi Pharmaceuticals Corp. (company) — Former name of Phio Pharmaceuticals Corp.
- Marlborough, MA (location) — Location of company's business address
- 2024-12-31 (date) — Fiscal year end date
- 2025-03-31 (date) — Filing date of the 10-K
FAQ
What is the primary business of Phio Pharmaceuticals Corp.?
Phio Pharmaceuticals Corp. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
When was Phio Pharmaceuticals Corp. formerly known as?
Phio Pharmaceuticals Corp. was formerly known as RXi Pharmaceuticals Corp., with a name change date of October 19, 2011.
Where is Phio Pharmaceuticals Corp. located?
The company's business and mailing address is 11 Apex Drive, Suite 300A, PMB 2006, Marlborough, MA 01752.
What is the SEC file number for Phio Pharmaceuticals Corp.'s 10-K filing?
The SEC file number for this 10-K filing is 001-36304.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Phio Pharmaceuticals Corp. (PHIO).